Multiple factors contribute to the growing number of reoperations for congenital and acquired cardiovascular diseases in the United States. Although the hazards are well-recognized, the health economic burden of resternotomy (RS) remains unclear and may be difficult to quantify. Contrary to published studies citing low frequencies of catastrophic hemorrhage and mortality, survey responses from practicing surgeons disclose higher rates of complications. Safety strategies in cardiac reoperation have generally involved efforts to maximize visualization during dissection, specialized surgical maneuvers and instrumentation, customized methods for establishing extracorporeal circulation, and techniques to prevent or avoid retrosternal adhesions. Yet, the relative cost-effectiveness of these strategies is largely unexplored. With the ongoing constraints in healthcare budgets, differentiating the value of existing and future approaches in terms of relative clinical benefits, costs, and impact on resource utilization will become increasingly important. We reviewed the relevant published literature in order to survey the morbidity and resource utilization associated with RS in cardiac reoperation and to identify key issues relevant for future studies.
Introduction
Despite noteworthy interventional advances, the number of patients undergoing resternotomies for cardiac reoperation continues to rise w1, 2x. Explanatory factors include improvements in overall longevity as well as survival following cardiac surgery w1, 3-5x, the expanding adult population requiring palliation for complex congenital malformations w4, 6, 7x, the persistence of progressive coronary artery disease w2x, and the ongoing fallibility of bioprosthetic valves w8-10x. Cardiac reoperation involving resternotomy (RS) can be technically challenging and has the potential for significant injury when compared to a primary operation w1x. Although the initial sternotomy is not typically hazardous, the ensuing formation of adhesions between the heart and mediastinal structures, including the sternum, increases the potential for complications during sternal reentry and dissection. Traditional RS techniques employing either an anterior or retrosternal approach afford the surgeon poor visualization, potentially leading to inadvertent bleeding and prolonged operation times w11x. Early studies in RS have documented a 1-8% incidence of catastrophic hemorrhage with resulting fatalities in over one-third of reported cases w12-14x.
Over the past decades, substantial efforts have culminated in two types of safety strategies: 1) the use of modified perioperative and operative maneuvers to avoid injury, and 2) preventative interventions aimed at minimizing mediastinal scarring. In the mid-1980s, early studies recommended a left thoracotomy approach for repeat coronary artery bypass w15x and as a means to avoid patent anterior grafts w16x. Later, Garrett and Matthews w17x portrayed sternal reentry using the oscillating saw on the anterior sternal table with wires left in place as a safe, expeditious method. In the 1990s, Eddy et al. w18x promoted dissecting adhesions under direct vision. Robicsek w19x used a Lebsche-knife and an osteotome for sternal reentry. Contemporary investigations continue to expand the armory of approaches, introducing innovative minimally invasive (MI) maneuvers and instrumentation, such as the robotic-enhanced endoscopic system w20, 21x. By implementing specific techniques in certain settings, recent studies assert that RS represents a negligible risk for perioperative cardiac injury as well as subsequent morbidity and mortality w5, 22x.
Yet, to date, current surgical practices have failed to embrace a universal paradigm for mitigating these risks. As the number of resternotomies continues to escalate, ongoing constraints in healthcare budgets will further curtail the market for competing innovations directed at improving the outcomes of cardiac reoperation. Thus, there is a pervasive need to distinguish safety strategies, as well as individual interventions, on the basis of their relative costDownloaded from https://academic.oup.com/icvts/article-abstract/11/3/277/813910 by guest on 28 March 2019 effectiveness. Currently, information concerning the health economic consequences of RS is sparse. Since determining the incremental burden of RS necessitates a clear understanding of the nature of complications and influence on health resource consumption, we reviewed the relevant published evidence as well as available data on the incidence of RS. Our objective was to survey the morbidity associated with RS in cardiac reoperation and the impact of treating and preventing complications on resource utilization.
Materials and methods

Search strategy and selection of eligible studies
Using keywords, we conducted comprehensive searches of the Medline, Embase, and the National Health Service Economic Evaluation DatabaseyHealth Technology Assessment databases, and manually searched reference citations. We included studies if they: 1) were published in English during the period January 1, 1998 through September 15, 2009; and 2) reported the outcomes of RS in cardiac reoperation; or 3) evaluated costs or resource utilization in this indication. Because cardiac reoperation may involve other techniques, we selected studies wherein RS was the approach in at least 75% of reoperations or in which median sternotomy was compared to an alternative approach. We excluded letters, commentaries, conference abstracts, review papers, and studies with sample sizes -50 resternotomies.
Definitions and data extraction
Following peer-review of the eligible studies, we tabulated selected outcomes data. We defined RS as a repeat sternotomy performed at least one month following the prior sternotomy and requiring a saw to reopen the full length of the sternum w22x. Catastrophic hemorrhage was defined as exsanguination resulting in hemodynamic deterioration and necessitating emergent intervention, such as blood transfusion or rapid institution of cardiopulmonary bypass (CPB). We collected data on morbidity, mortality, and resource utilization imposed by events occurring during sternal reentry, dissection of the sternum away from underlying cardiac structures, and dissection of cardiovascular structures required to achieve the surgical objective. In most cases, this period was characterized as the time commencing from skin incision to initiation of CPB. We considered injury to cardiac structures and catastrophic hemorrhage as the primary adverse events for this interval.
Because intraoperative difficulties may impact certain parameters, we examined surrogate indices for resource utilization, including the use of preoperative imaging to assess retrosternal structures, institution of preoperative extrathoracic cannulation, emergent transfusions, and emergent CPB. We also extracted data on operation and dissection time, prolonged mechanical ventilation, and hospital and intensive care unit length of stay, comparisons of RS and primary sternotomy, as well as information on resources expended in anticipating and treating complications. Finally, in order to identify issues deemed clinically important in the literature, we categorized the studies as either an: A) evaluation of technique; or B) analysis of complications or risk factors.
Results
Prevalence of cardiac conditions potentially requiring reoperation
Data on population trends, the prevalence of cardiac disease, and the incidence of cardiac reoperation suggest that the number of resternotomies in the United States will continue to rise w23-25x. Commensurate with increasing longevity in the general population, the survival of individuals potentially requiring cardiac reoperation is also improving w23x. In 2006, approximately 80 million (one in three) American adults harbored one or more acquired types of cardiovascular disease, of whom 16.8 million had coronary heart disease. From 1995 to 2005, death rates from cardiovascular disease declined from approximately 281 per 100,000 population to 220 per 100,000 population, reflecting improvements in both treatment and life expectancy w24, 25x. Similarly, mortality from congenital heart defects has also decreased; more than 95% of infants born with complex cardiac anomalies survive to adulthood w7x. 
Literature search results
Twenty-nine publications met the inclusion criteria, of which the majority (25 of 29, 86%) were retrospective and included adult patients (i.e. 79% or 22 of 28 studies with data). Studies assessing perioperative or surgical techniques and those examining complications or risk factors were nearly equal in number (15 vs. 14, respectively). Patients among the studies appeared heterogeneous with respect to interventions and reoperative indications ( Table 1) .
Catastrophic hemorrhage and mortality in resternotomy
Sixty-six cases of catastrophic hemorrhage occurred among 3640 (1.5%) patients from 15 studies providing Morales et al., the only study comparing catastrophic hemorrhage in RS cases and concurrent primary sternotomy controls, observed no significant group differences (two of 602, 0.3% vs. zero of 1274, respectively) w22x. The collaborators performed no preoperative imaging specifically for RS, but employed a stepwise surgical approach, which facilitated visualization of adherent vascular structures during retrosternal dissection. In Elahi et al., complication rates for pediatric congenital defect RS cases and controls also did not differ significantly w6x. Most patients underwent operation under moderate hypothermia and cardioplegic arrest and one-third (25 of 75) had preoperative femorofemoral bypass.
Cardiac injuries and timing of injuries
Twenty-two studies (75.8%) documented major injuries or minor lacerations to cardiac structures, grafts, and conduits. Among 11 studies citing data, injuries occurred during sternal reentry in three w14, 28, 42x, retrosternal dissection in two w27, 28x, and during both stages in six w5, 22, 35, 38, 45, 47x. Roselli et al. characterized 145 intraoperative adverse events (IAEs) in 127 patients and observed that 34 (23%) IAEs had occurred during sternal reentry, 57 (39%) during pre-pump dissection, and 34 (23%) during CPB w45x. Fewer injuries occurred during aortic clamping (6%) and sternal closure (8%). Injuries to bypass grafts occurred more often than injuries to the heart (32% vs. 26%, respectively) with the internal thoracic artery being most frequently damaged.
Health resource consumption in the treatment of cardiac injuries
The majority of catastrophic hemorrhage cases (55 of 66; 83.3%) required emergent placement on CPB w1, 4, 5, 14, 22, 29, 33, 38, 42, 47x ; 10 (15.2%) cases received emergent blood or blood product transfusions. Twenty-six additional unplanned interventions were performed for cardiac injuries not resulting in catastrophic hemorrhage w4, 6, 28, 35, 38, 42, 45x , and included alterations in operative strategy (ns4) and supplemental surgical maneuvers (ns16). Four patients with univentricular hearts had suspected air embolism following laceration of the right atrium; all cases required diagnostic head computer tomography imaging and two required hyperbaric oxygen therapy and surgical repair w4, 6x.
Among 12 studies, the incidence of bleeding necessitating reoperation following RS ranged from 1.3 to 6% w1, 5, 22, 26, 31, 33, 36-38, 40x . Sternal wound infections affected approximately 0.5 to 5% of cases w1, 5, 22, 27, 28, 30, 31, 34, 35x ; only three studies reported episodes of sternal wound dehiscence w1, 22, 31x. In Yau et al., bleeding requiring reoperation and sternal wound infection occurred more frequently in RS cases compared to concurrent primary sternotomy controls (2.9% vs. 2.2%, respectively, for each complication, P)0.0001 for the incidence of reoperation) w32x.
Preventative interventions and strategies
Preventative strategies generally employed one or more of the following tactics: 1) technologies to improve visualization during dissection, 2) customized extracorporeal circulation methods, 3) specialized instrumentation or technique to facilitate sternal reentry or dissection, andy or 4) measures to prevent or avoid adhesions (Fig. 1) . Follis et al. indicated that in high-risk cases, 73% (819 of 1115) of the STS respondents favored exposing femoral vessels, 39% (445 of 1116) would initiate preoperative bypass, and 30% (342 of 1115) would consider MI techniques w14x. Among preoperative measures, computed tomography (CT) imaging enabled identification of vulnerable cases in high-risk valve (i.e. third or fourth sternotomy) and coronary artery bypass grafting (CABG) reoperations, resulting in peripheral vessel cannulation prior to sternal reentry, the avoidance of patent grafts, and reduced rates of catastrophic hemorrhage w38, 46x ( Table 2) .
Non-emergent alterations in CPB, such as preoperative CPB and off-pump bypass grafting, were also associated with lower rates of catastrophic hemorrhage and bleeding requiring reoperation compared to controls w6, 44x. Establishing preoperative CPB via a bicaval femoral venous cannula designed for MI surgery, Kuralay et al. observed no injuries among 100 patients undergoing repeat valvular or congenital heart repairs, whereas six of 100 patients cannulated conventionally (ascending aorta and right atrium) incurred severe cardiac injuries (Ps0.029) w1x.
Assessing surgical instrumentation, Athanasiou et al. found that video-assisted retrosternal dissection (VAR) with the Mayfield retractor reduced the incidence of RS cardiac injuries and the need for CPB compared to the oscillating saw w33x. Likewise, compared to traditional electrocautery and scissors, dissecting pericardial adhesions via the harmonic scalpel was associated with fewer cardiac injuries, major arrhythmias, and minor complications w39x. Three studies evaluated surgical materials applied during the prior sternotomy. Elahi et al. noted the incidence of injuries during sternal reentry was significantly lower in patients whose pericardial sac had been previously closed than in those who were repaired using DacronyGortex material (P-0.001) w3x. Similarly, Kirshbom et al. found that pediatric congenital heart patients who underwent substernal placement of a polytetrafluoroethylene membrane demonstrated an increased likelihood of reentry injury (three of 20, 15%) compared to those without membranes (10 of 980, 1%; P-0.0001) w47x. In contrast, Lodge et al. reported no differences between neonates randomized to prior bioresorbable barrier film placement and controls w28x. 
Sharony et al. and Burfeind et al. compared MI approaches
wincluding mini-thoracotomy, right thoracotomy (RT), and Port-Accessx and median RS in adult patients undergoing valve reoperation, but neither study accounted for cardiac injuries w27, 34x. Svensson et al. found that compared to repeat median sternotomy, RT conferred a higher risk for stroke and reduced likelihood of mitral valve repair, but was not associated with higher mortality w43x.
Finally, two studies documented resource consumption associated with complications from precautionary interventions. In Merin et al., 11 of 94 (11.7%) patients undergoing preoperative femoral vessel cannulation experienced femoral artery trauma requiring vein interposition (ns1), laparotomy (ns1), treatment for wound infections (ns5) and groin hematoma (ns4) w30x. Kuralay et al. w1x also recorded five (5%) cases of wound infection from femoral vessel cannulation, but did not elaborate on treatment or outcomes.
Impact of precautionary interventions on blood transfusion requirements and measures of resource utilization
Several studies demonstrated trends for lower blood transfusion requirements with specific measures, such as femoral bypass prior to sternal reentry w1, 6x, use of the harmonic scalpel w39x, VAR with the Mayfield retractor w33x, off-pump coronary artery bypass grafting (OPCABG) w44x, and use of a mini-thoracotomy approach w27, 34x (Table 3) . Preoperative femoral bypass w 1, 3x, dissection using the harmonic scalpel w39x, or bioresorbable barrier film placement in the initial sternotomy w28x, also resulted in trends for shorter duration of dissection time, operative time, mechanical ventilation, and length of hospitalization and intensive care unit stay; however, with few exceptions w27x, the differences between comparator groups were marginal.
Costs of resternotomy
None of the studies explicitly cited costs. In Roselli et al., the ratio of median direct technical costs for patients experiencing IAEs to those without IAEs was 1.3 (68% confidence interval 1.16-1.4), favoring higher costs for the former due to compensatory postoperative rescue measures w45x. Cremer et al. speculated that preoperative CT scanning would reduce costs by avoiding complications and by sparing resources for exposing femoral vessels w29x. In Sharony et al., blood bank charges were 23.9% lower for MI isolated valve reoperation than for conventional RS w27x.
Is resource consumption higher in resternotomy compared to primary sternotomy?
Reoperative pediatric congenital defect cases in Russell et al. w4x and Elahi et al. w6x demonstrated significantly longer hospital and intensive care unit length of stay and significantly increased CPB and cross-clamp times compared to primary sternotomy cases w4, 8x. Although blood requirements did not differ between the two groups in either study, patients were transfused significantly more frequently during initial operations. Both studies attributed the within-subjects differences to the heightened risk of coagulopathy possibly related to surgical complexity and younger age at prior sternotomy w4, 6x. Yau et al. compared resource utilization during two periods for 1230 coronary artery reoperative cases and 19,384 primary revascularization cases w32x. From 1990 to 1994, ventilation times and intensive care unit and postoperative hospital length of stay were significantly longer for RS than for primary sternotomy, but did not differ significantly during the subsequent period. Reductions in the reoperative group were attributed to a 'fast-track' perioperative strategy implemented during the latter period.
Discussion
With the rising number of cardiac reoperations, RS remains a necessary, common part of modern cardiac surgical practice despite its recognized hazards. Although the literature publicizes the risks, very few studies have attempted to quantify the net incremental health economic Downloaded from https://academic.oup.com/icvts/article-abstract/11/3/277/813910 by guest on 28 March 2019 infection or dehiscence'. CPB, cardiopulmonary bypass; RS, resternotomy; MI, minimally invasive; ND, not determined for resternotomy by available data; NR, not reported; OSG, oscillating saw technique; VAR, video-assisted retrosternal dissection; RT, right thoracotomy; CT, computed tomography; CABG, coronary artery bypass grafting; OPCABG, off-pump coronary artery bypass grafting. burden of RS, and thus, its impact on the healthcare system remains unclear. Several limitations arise when addressing this issue. First, the incidence of RS is not well-defined. Using the STS and Healthcare Cost and Utilization Project (HCUP) data, we might conservatively deduce that at least 50,000 resternotomies are performed in the U.S. annually. However, individual surgical practices projecting the budgetary impact of RS must also account for the periodicity of reoperations determined by their specific patient mix. Second, estimating the burden of RS is compromised by the quality of published evidence. The majority of studies were retrospective, observational accounts, which are notoriously vulnerable to biases. Attempting to compensate for under-reporting, we scrutinized the studies for events meeting our catastrophic hemorrhage definition. The overall published incidence (1.6%) fell within the previouslyreported range and seemingly supported recent contentions that RS confers a marginal risk w5, 15x. However, the discrepancy between the published injury rates and survey findings is noteworthy. Both Follis et al. and Dobell and Jain, a study published 15 years earlier, noted substantially higher rates of catastrophic hemorrhage (2046 cases among 1116 respondents and 144 cases among 131 surgeons, respectively). More recently, Roselli found that injuries occurred regularly during reoperation, particularly during dissection. Together, these 'real-world' data underscore our suspicion that catastrophic hemorrhage may be underreported in the literature. Although this may reflect the tendency to publicize more favorable outcomes, the disparity suggests that RS can be successfully managed under controlled conditions, but in common practice, still poses significant risks.
From a health economic perspective, the published evidence suggests that utilizing certain safety measures in However, cost-effectiveness studies of preventative strategies in RS, are currently lacking. This may be due to the fact that comparative effectiveness trials are challenged by inadequate sample size, lack of suitable controls, and difficulty in follow-up, thereby requiring careful selection of the study population. For example, when evaluating primary sternotomy interventions, one must consider that the interval between the first operation and RS may be protracted (e.g. )12 years for post-CABG patients). In this regard, patients with left ventricular assist devices may be suitable due to the typical shorter time 'bridge' between the primary device surgery and reoperation for transplantation. Alternatively pediatric patients requiring single ventricle palliation who often undergo a Glenn procedure within months of initial palliation may be considered.
Given these limitations, how do we measure the costeffectiveness of safety measures? First, the baseline health economic burden of RS must be recognized from the perspectives of selected stakeholders and society as a whole. Despite the paucity of studies, there is evidence that certain potential complications of RS, such as the need for blood transfusion, can increase variable healthcare costs w48-50x. Applying cost estimates for hospital resources to published complication rates, we might estimate that for every 100 cases undergoing cardiac reoperation, resource consumption in RS may increase the direct healthcare costs by over $2.4 million ( Table 4) .
The indirect costs of RS are less apparent, but include the costs for labor, third-party services, and all processes involved in the development, manufacturing, and implementation of safety measures, including technologies and specialized operative techniques. These expenditures most likely contribute substantially to the overall burden of RS. A recent activity-based costing model evaluating expenditures in a surgical population found that the indirect costs for providing transfusion services, including overhead costs, increased the costs for blood acquisition by nearly 3.2 to 4.8-fold w49x. Prolonged hospital stay and morbidity also lead to productivity losses, while the intangible toll relating to pain, suffering, and loss of quality of life following RS must also be weighed.
Recommending a method for curbing resource utilization is arduous without the benefit of cost-effectiveness evaluation. A cost-effective strategy would yield optimal patient outcomes at acceptable costs to relevant stakeholders, including payers, healthcare providers, and society. In assessing direct costs, technologies designed for per-patient use are frequently construed to be expensive because heightened utilization generates higher costs. However, such interventions might be used discriminately in higherrisk cases. For example, a cost-effectiveness analysis for a biomaterial intended to minimize adhesion formation following primary sternotomy might weigh the costs of the biomaterial and its application against the costs saved by avoiding blood transfusions and related risks during RS. If, hypothetically, the direct cost of the biomaterial per application is $100, treating 100 RS cases would cost a healthcare provider an excess of $10,000. Based on published data, approximately 2 to 84% of cases require blood transfusions. At the lower estimate, and assuming an average cost of $2000 per transfusion, avoiding transfusions in two cases may result in a net total expenditure of $6000. In contrast, applying the biomaterial in a higher-risk population, wherein 10 cases avoid transfusion, a healthcare system may net a cost savings of $10,000. Although simplistic, this analysis offers a straightforward methodology for assessing cost-effectiveness while simultaneously accounting for the intervention's effectiveness, the patient risk profile for a given surgical indication andyor healthcare system, and potential expenditures and medical cost-offsets. Surgical practices may be encouraged to individually evaluate new andyor existing safety strategies through similar analyses tailored to their specific clinical milieu. We acknowledge several limitations. First, our search may have excluded important studies by eliminating those investigating multiple surgical approaches, but for which, we could not determine the outcomes. Although we scrutinized the studies for conspicuous cases, our pre-established definition of catastrophic hemorrhage was prone to bias. Because we intended to survey the burden of RS, we did not attempt to control for risk factors, categorize studies by surgical indication or patient population, or account for the study time period. These additional steps would be useful in more precisely quantifying the incidence of complications in specific populations.
Understanding the health economic implications of RS in cardiac reoperation requires thorough consideration of both explicitly reported outcomes and implicit consumption of resources expended in minimizing injury. Additionally, the indirect costs and effects on patient-reported outcomes must also be weighed. However, given the heterogeneity of surgical practices, standardizing measures across institutions is a formidable challenge. If effective, adjunctive preventative measures, such as those directed at minimizing mediastinal scarring following prior sternotomy, may offer a suitable solution in reducing injury. However, the cost-benefit of these interventions remains yet to be explored.
